11.01.26 -- Beyond Australia: Why Medtech Startups Are Re-Evaluating FIH Trial Destinations

FEATURED EDITORIAL

Beyond Australia: Why Medtech Startups Are Re-Evaluating FIH Trial Destinations

By Julio G. Martinez-Clark, Bioaccess

The advice handed to medtech companies planning a first-in-human (FIH) study has been: go to Australia. That advice is now overdue for a rewrite. Not because Australia stopped working, but because the math changed.

Beyond Australia: Why Medtech Startups Are Re-Evaluating FIH Trial Destinations

By Julio G. Martinez-Clark, bioaccess

The advice handed to medtech companies planning a first-in-human (FIH) study has been: go to Australia. That advice is now overdue for a rewrite. Not because Australia stopped working, but because the math changed.

INDUSTRY INSIGHTS

The Hidden Costs Of Multiple-Vendor Contract Manufacturing

Pharma & MedTech Partner Division, B. Braun Medical Inc.

Startup Decision Guide: Right-Size Your Life Science QMS

MasterControl, Inc.

Planning For Scale Up: Building For Long Term Flexibility

West Pharmaceutical Services, Inc.

Medbio: Helping To Reduce Supplier Complexity In Drug Delivery Manufacturing

Medbio

Advancing Biopsy Device Performance Through Precision Overmolding

SMC Ltd.

Continuous Readiness Is Becoming The New Operating Standard In MedTech

Qualio

What 9 Years Of MDR Experience Is Changing About PMCF Planning

Castor

Meeting The Demands Of Pulse Power Applications

Knowles Precision Devices DLI

Improve Flow Cell Performance While Cutting System Costs

The Lee Company
Connect With Med Device Online: